parkinson’s

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease PatientsSerina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients

HUNTSVILLE, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced…

3 months ago
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker AssaysAlamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays

Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays

FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of…

4 months ago
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker AssaysAlamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays

Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays

FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of…

4 months ago
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker AssaysAlamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays

Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays

FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of…

4 months ago